Tapio Visakorpi

Papers

Total Citations

H-Index

About

Tapio Visakorpi is a leading figure in prostate cancer research, whose work has fundamentally advanced our understanding of the disease’s molecular biology and diagnostic pathology. His key research areas center on the genetic and epigenetic mechanisms driving prostate cancer progression, with a particular focus on developing robust tissue preparation methods that bridge clinical diagnostics and molecular research. Visakorpi’s major contributions include pioneering the evaluation of PAXgene fixation as a viable alternative to traditional formalin-fixed paraffin-embedded (FFPE) and fresh frozen tissue processing. His highly cited 2017 study, “Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology,” demonstrated that PAXgene-fixed tissues preserve high-quality DNA, RNA, and proteins while maintaining excellent histomorphology, enabling seamless integration of clinical and molecular analyses. This work has profound implications for biomarker discovery and personalized medicine, as it allows researchers to extract reliable molecular data from routine clinical specimens. With over 20 citations, this study underscores Visakorpi’s impact on translational oncology. His achievements have positioned him as a key innovator in prostate cancer diagnostics, making his research indispensable for students and scientists seeking to improve cancer patient outcomes through precision pathology.